Although mutation of NOTCH1 or NOTCH2 only occurs in a small proportion of breast cancer cases, inclusion of cases harboring both mutation and overexpression accounts for 30% of poor-prognosis TNBC cases. Here, NOTCH1 is linked to breast cancer.